Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2026)

Guardian Pharmacy Services' Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$4.8 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 14.34% year-over-year to -$4.8 million; the TTM figure through Mar 2026 stood at -$31.4 million (up 2.86% YoY), while the FY2025 annual figure was -$32.2 million, down 5.98% from the prior year.
• Cash from Investing Activities came in at -$4.8 million for Q1 2026 at Guardian Pharmacy Services, down from -$4.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$1.1 million in Q4 2023 to a low of -$13.1 million in Q2 2024.
• A 4-year average of -$6.9 million and a median of -$6.1 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities slumped 477.51% in 2024 and rose 28.89% in 2025, its largest moves.
• Guardian Pharmacy Services' Cash from Investing Activities stood at -$1.1 million in 2023, then plunged by 477.51% to -$6.6 million in 2024, then grew by 28.89% to -$4.7 million in 2025, then dropped by 0.85% to -$4.8 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$4.8 million, -$4.7 million, and -$9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison